L-Nutra is the leading nutritechnology company, developing innovative Fasting Mimicking & Enhancing™ Diets (FMEDs™) that can be consumed for a predetermined number of consecutive days, with the frequency dependent on the condition and patient. FMEDs™ nourish the body while keeping it in a fasting mode, which promotes positive long-term effects on biological aging, health and a variety of other factors, such as weight, abdominal fat , and maintaining healthy levels of glucose, cholesterol, blood pressure, and other key health factors.
L-Nutra’s first generation of FMEDs™ includes ProLon® and Chemolieve®. ProLon® is a 5-day FMED™ aimed at promoting longevity, managing body weight, and improving health by supporting cellular protection, multi-system regeneration and rejuvenation. ProLon® will be launched in the United States in 2016. Chemolieve® is a 4-day FMED™ being studied for use with oncology patients to protect the normal cells of the body and decrease side effects of chemotherapy without interfering with its efficacy.